Fatima Zeba

Fatima Zeba is an Assistant Professor in the Department of Pulmonary, Critical Care & Sleep Medicine at Yale School of Medicine, with a primary appointment in Internal Medicine. She is actively involved in clinical care, research, and academic medicine at Yale.

Education:

• MBBS, Kasturba Medical College, Manipal (2016)
• MD, Internal Medicine Residency, Kent Hospital/Brown University (2020)
• MD, Pulmonary Critical Care Medicine Fellowship, Dartmouth Hitchcock Medical Center (2023)
• Advanced Applied Biostatistics Certificate, Harvard Catalyst (2025, expected)

Her research interests focus on pulmonary and critical care medicine, particularly in the areas of imaging biomarkers in interstitial lung disease, sepsis management, ICU outcomes related to opioid use, cardiopulmonary interactions in pulmonary embolism, and lung function as a predictor of cardiovascular risk. She employs clinical data, radiological analysis, and outcomes research methodologies.

Her recent publications reflect a strong trend in clinical and translational research in pulmonary and critical care. Key themes include prognostic imaging markers in fibrotic lung disease, antibiotic timing in sepsis, fluid responsiveness assessment using ultrasound, and the impact of opioid use in the ICU. Her work frequently appears in high-impact journals such as Critical Care Medicine, Lung, PLOS ONE, and Chest.

She is board certified in Internal Medicine (2020), Pulmonary Disease (2022), and Critical Care Medicine (2024) by the American Board of Internal Medicine.

Dr. Zeba is engaged in educational initiatives, including presenting at national conferences (CHEST) and contributing to simulation-based learning tools like a ventilator game. She is affiliated with the Yale Center for Clinical Investigation (YCCI) and conducts research supported by institutional resources. There are no public records of scientific awards or formal advisees at this time. Her clinical and research work is based at Yale New Haven Hospital and affiliated research sites.